FR3113834B1 - Compositions cosmétiques comportant du rétinol stabilisé - Google Patents

Compositions cosmétiques comportant du rétinol stabilisé Download PDF

Info

Publication number
FR3113834B1
FR3113834B1 FR2009032A FR2009032A FR3113834B1 FR 3113834 B1 FR3113834 B1 FR 3113834B1 FR 2009032 A FR2009032 A FR 2009032A FR 2009032 A FR2009032 A FR 2009032A FR 3113834 B1 FR3113834 B1 FR 3113834B1
Authority
FR
France
Prior art keywords
weight
cosmetic compositions
retinol
cosmetic composition
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2009032A
Other languages
English (en)
Other versions
FR3113834A1 (fr
Inventor
Jonathan James Faig
David Chan
Susan Halpern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR2009032A priority Critical patent/FR3113834B1/fr
Priority to JP2022580828A priority patent/JP2023532088A/ja
Priority to EP21742658.4A priority patent/EP4171476A1/fr
Priority to KR1020237000814A priority patent/KR20230022440A/ko
Priority to PCT/US2021/039523 priority patent/WO2022006054A1/fr
Priority to CN202180047227.XA priority patent/CN115803000A/zh
Publication of FR3113834A1 publication Critical patent/FR3113834A1/fr
Application granted granted Critical
Publication of FR3113834B1 publication Critical patent/FR3113834B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Abstract

Compositions cosmétiques comportant du rétinol stabilisé Une composition cosmétique incluant environ 0,01 à environ 3 % en poids de rétinol ; environ 0,01 à environ 1 % en poids d’hydroxyhydrocinnamate de tétra-di-t-butyle ; environ 0,01 à environ 3 % en poids d’éthylènediamine disuccinate trisodique ; environ 0,5 à environ 7 % en poids de distéarate de polyglycéryl-3 méthylglucose ; environ 0,9 à environ 7 % en poids de polyacrylate de sodium ; environ 0,5 à environ 8 % en poids d’une phase huileuse ; et de l’eau, où tous les pourcentages en poids sont basés sur le poids total de la composition cosmétique. De surcroît, la composition cosmétique est typiquement formulée pour former une émulsion huile dans l’eau. Des procédés de traitement de la peau endommagée avec des compositions cosmétiques sont également divulgués ici. Figure pour l'abrégé : néant
FR2009032A 2020-06-30 2020-09-07 Compositions cosmétiques comportant du rétinol stabilisé Active FR3113834B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR2009032A FR3113834B1 (fr) 2020-09-07 2020-09-07 Compositions cosmétiques comportant du rétinol stabilisé
JP2022580828A JP2023532088A (ja) 2020-06-30 2021-06-29 安定化レチノールを有する化粧品組成物
EP21742658.4A EP4171476A1 (fr) 2020-06-30 2021-06-29 Compositions cosmétiques ayant du rétinol stabilisé
KR1020237000814A KR20230022440A (ko) 2020-06-30 2021-06-29 안정화된 레티놀을 갖는 화장료 조성물
PCT/US2021/039523 WO2022006054A1 (fr) 2020-06-30 2021-06-29 Compositions cosmétiques ayant du rétinol stabilisé
CN202180047227.XA CN115803000A (zh) 2020-06-30 2021-06-29 具有稳定视黄醇的美容组合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2009032A FR3113834B1 (fr) 2020-09-07 2020-09-07 Compositions cosmétiques comportant du rétinol stabilisé
FR2009032 2020-09-07

Publications (2)

Publication Number Publication Date
FR3113834A1 FR3113834A1 (fr) 2022-03-11
FR3113834B1 true FR3113834B1 (fr) 2023-12-08

Family

ID=73401750

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2009032A Active FR3113834B1 (fr) 2020-06-30 2020-09-07 Compositions cosmétiques comportant du rétinol stabilisé

Country Status (1)

Country Link
FR (1) FR3113834B1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262603A (en) 1992-05-12 1993-11-16 Miller Edge, Inc. Sensing edge
JP2832143B2 (ja) 1993-12-28 1998-12-02 信越化学工業株式会社 シリコーン微粒子およびその製造方法
KR100258674B1 (ko) * 1997-09-12 2000-07-01 서경배 안정성이 개선된 레티노이드를 함유하는 친수형 화장료의 제조방법
FR2818547B1 (fr) 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation

Also Published As

Publication number Publication date
FR3113834A1 (fr) 2022-03-11

Similar Documents

Publication Publication Date Title
Whelton et al. Magnesium and blood pressure: review of the epidemiologic and clinical trial experience
Hill et al. Improvement in the symptoms of smooth muscle dystonia during eculizumab therapy in paroxysmal nocturnal hemoglobinuria
FR3094373B1 (fr) Emulsion inverse pour la fracturation hydraulique
FR2374896A1 (fr) Emulsions pour cosmetiques a proportion elevee de phase interne et procede pour leur preparation
WO2007059888A3 (fr) Emulsions speciales
FR2981567B1 (fr) Composition cosmetique comprenant un tensioactif gemine et de forts taux de corps gras solide.
EA201001439A1 (ru) Трехфазная эмульсия (варианты), способ ее приготовления и нанесения
FR3113834B1 (fr) Compositions cosmétiques comportant du rétinol stabilisé
FR3088548B1 (fr) Composition comprenant un derive d’acide cinnamique et un polymere cellulosique non ionique non associatif
FR3108843B1 (fr) Composition cosmétique pour soin de la peau
FR3114025B1 (fr) Composition cosmétique comportant du rétinol stabilisé
Wenzel et al. Combination treatment of enalapril with nitrendipine in rats with renovascular hypertension.
FR3113836B1 (fr) Composition cosmétique pour pénétration améliorée
FR2400889A1 (fr) Procede de preparation d'emulsions eau-dans-l'huile ou huile-dans-l'eau a faible teneur en eau et contenant de la poudre de polyethylene, et emulsions ainsi obtenues
FR3102479B1 (fr) Emulsion inverse pour la fracturation hydraulique
FR3113835B1 (fr) Composition cosmétique procurant des sensations uniques
FR3113833B1 (fr) Composition cosmetique contenant du retinol
Case et al. Renal cortical blood flow and angiography in low-and normal-renin essential hypertension
FR3098113B1 (fr) Composition sous forme d’émulsion huile-dans-eau avec une phase grasse sous forme de gouttes et d’agrégats
FR3112286B1 (fr) Emulsion eau dans huile à haute teneur en phase interne aqueuse
RU94041218A (ru) Металлический сплав
WO2004064749A3 (fr) Reduction de la pousse des cheveux
FR3111545B1 (fr) Composition cosmetique pour application sur la peau contenant une haute quantite de polyol(s)
AU601238B2 (en) A method of treatment of pregnancy induced hypertension
FR3121041B1 (fr) Composition à deux phases

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20220311

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4